RSS Feeds
Search

Press releases

Press releases

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
US Oncology, Inc. - Strategy and SWOT Report
Jun 2011 - 34 pages - $125
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Bone Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 109 pages - $1,000
Molecular Targeted Cancer Therapies Market Forecast
Aug 2009 - $15,200
Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
Mar 2008 - 100 pages - $3,800
Cancer Targeted Therapies and Immunotherapies Market Forecast
Aug 2010 - $15,200
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Patents del
Therapeutic target
Oncology del
Bone cancer del
Year
2007 del

Browse By

Therapeutic target
Chondrosarcoma
Ewings Sarcoma
Osteosarcoma
Spindle sarcoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us